RESUMO
One of the causes of diabetes in infants is the defect of the insulin gene (INS). Gene mutations can lead to proinsulin misfolding, an increased endoplasmic reticulum (ER) stress and possible beta-cell apoptosis. In humans, the mechanisms underlying beta-cell failure remain unclear. We generated induced pluripotent stem cells (iPSCs) from a patient diagnosed with neonatal diabetes mellitus carrying the INS mutation in the 2nd intron (c.188-31G>A) and engineered isogenic CRISPR/Cas9 mutation-corrected cell lines. Differentiation into beta-like cells demonstrated that mutation led to the emergence of an ectopic splice site within the INS and appearance of the abnormal RNA transcript. Isogenic iPSC lines differentiated into beta-like cells showed a clear difference in formation of organoids at pancreatic progenitor stage of differentiation. Moreover, MIN6 insulinoma cell line expressing mutated cDNA demonstrated significant decrease in proliferation capacity and activation of ER stress and unfolded protein response (UPR)-associated genes. These findings shed light on the mechanism underlying the pathogenesis of monogenic diabetes.
Assuntos
Diabetes Mellitus , Células-Tronco Pluripotentes Induzidas , Células Secretoras de Insulina , Diferenciação Celular/genética , Proliferação de Células/genética , Diabetes Mellitus/metabolismo , Estresse do Retículo Endoplasmático/genética , Humanos , Células-Tronco Pluripotentes Induzidas/metabolismo , Recém-Nascido , Células Secretoras de Insulina/metabolismo , MutaçãoRESUMO
BACKGROUND: Conditional deletion of the tumour suppressor gene Apc within the murine intestine results in acute Wnt signalling activation. The associated over-expression of a myriad of Wnt signalling target genes yields phenotypic alterations that encompass many of the hallmarks of neoplasia. Previous transcriptomic analysis aimed at identifying genes that potentially play an important role in this process, inferred the Hormonally upregulated Neu-associated kinase (HUNK/Mak-v/Bstk1) gene as a possible candidate. Hunk is a SNF1 (sucrose non fermenting 1)-related serine/threonine kinase with a proposed association with many different tumour types, including colorectal cancer. METHODS: Here we describe the generation of a novel Hunk kinase deficient mouse which has been used to investigate the involvement of Hunk-kinase activity in intestinal homeostasis and tumourigenesis. RESULTS: We show that in the morphologically normal intestine, Hunk-kinase negatively regulates epithelial cell proliferation. However, the increase in cell proliferation observed in the Hunk kinase deficient intestine is counteracted by increased cell migration, thereby maintaining intestinal homeostasis. Using qRT-PCR, we further demonstrate that Hunk is significantly over-expressed in Apc deficient / Wnt-signalling activated intestinal tissue. Using the classical intestinal tumourigenesis Apc (Min) mouse model we show that loss of Hunk-kinase activity significantly reduced tumour initiation rates in the small intestine. However, an accompanying increase in the size of the tumours counteracts the impact this has on overall tumour burden or subsequently survival. CONCLUSIONS: In the intestinal setting we demonstrate that Hunk has a role in normal intestinal proliferation and homeostasis and, although it does not alter overall survival rates, activity of this kinase does impact on tumour initiation rates during the early stages in tumourigenesis in the small intestine.
Assuntos
Mucosa Intestinal/metabolismo , Proteínas Quinases/genética , Proteínas Quinases/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Proliferação de Células , Transformação Celular Neoplásica/genética , Transformação Celular Neoplásica/metabolismo , Modelos Animais de Doenças , Células-Tronco Embrionárias/metabolismo , Feminino , Regulação da Expressão Gênica , Técnicas de Silenciamento de Genes , Marcação de Genes , Loci Gênicos , Masculino , Camundongos , Dados de Sequência Molecular , Neoplasias/genética , Neoplasias/metabolismo , Neoplasias/mortalidade , Neoplasias/patologia , Proteínas Quinases/deficiência , Proteínas Serina-Treonina Quinases , Carga Tumoral , Regulação para Cima , Via de Sinalização WntRESUMO
Adenovirus-based drugs are efficient when combined with other anticancer treatments. Here we show that treatment with LY294002 and LY303511 upregulates expression of recombinant proteins encoded by replication-defective adenoviruses, including expression of therapeutically valuable combination of herpes simplex virus thymidine kinase controlled by human telomerase reverse transcriptase promoter (Ad-hTERT-HSVtk). In line with this, treatment with LY294002 synergized with Ad-hTERT-HSVtk infection in the presence of gancyclovir prodrug on Calu-I lung cancer cell death. The effect of LY294002 and LY303511 on adenovirus-delivered transgene expression was demonstrated in 4 human lung cancer cell lines. LY294002-induced upregulation of adenovirally delivered transgene is mediated in part by direct inhibition of mTOR protein kinase in mTORC2 signaling complex thus suggesting that anticancer drugs targeting mTOR will also enhance expression of transgenes delivered with adenoviral vectors. As both LY294002 and LY303511 are candidate prototypic anticancer drugs, and many mTOR inhibitors for cancer treatment are under development, our results have important implication for development of future therapeutic strategies with adenoviral gene delivery.
Assuntos
Adenoviridae/metabolismo , Cromonas/farmacologia , Morfolinas/farmacologia , Serina-Treonina Quinases TOR/metabolismo , Adenoviridae/genética , Antineoplásicos/farmacologia , Western Blotting , Linhagem Celular Tumoral , Citometria de Fluxo , Expressão Gênica/efeitos dos fármacos , Humanos , Piperazinas/farmacologia , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Serina-Treonina Quinases TOR/genéticaRESUMO
Pdcd4 (programmed cell death 4) gene is tumor suppressor which expression is frequently down-regulated in tumors, which is considered as a diagnostic and prognostic marker as well as promising target for anti-cancer therapy. Pdcd4 protein is a target for post-translational regulation by phosphorylation marking Pdcd4 for degradation. We questioned if Pdcd4 mRNA decline in human lung tumors is accompanied by proportional depletion of Pdcd4 protein. We found that Pdcd4 protein-to-mRNA ratio varies greatly in human lung cancer cell lines. In squamous cell carcinoma samples where Pdcd4 mRNA suppression was found to be a typical event, Pdcd4 protein level frequently remained unchanged or even up-regulated. Our studies demonstrate that at least in squamous cell carcinoma, alterations in Pdcd4 mRNA and protein levels are not directly linked, and this fact should be taken into consideration when developing Pdcd4-based anti-cancer therapeutic approaches.
Assuntos
Proteínas Reguladoras de Apoptose/biossíntese , Carcinoma de Células Escamosas/metabolismo , Neoplasias Pulmonares/metabolismo , RNA Mensageiro/biossíntese , Proteínas de Ligação a RNA/biossíntese , Proteínas Reguladoras de Apoptose/análise , Western Blotting , Carcinoma de Células Escamosas/genética , Linhagem Celular Tumoral , Humanos , Imuno-Histoquímica , Neoplasias Pulmonares/genética , RNA Mensageiro/análise , Proteínas de Ligação a RNA/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Transcrição Gênica , TransfecçãoRESUMO
Rabaptin-5 is an important component of intracellular vesicular transport machinery. In this report, we describe a novel Rabaptin-5gamma transcript which has a 120 nt deletion in coding region of Rabaptin-5 messenger RNA (mRNA). We also cloned the 5'part of Rabaptin-5delta transcript and showed that upstream previously described deletion, Rabaptin-5delta mRNA is identical to Rabaptin-5. Both deletions are in-frame and result in excision of 40 and 43 aa, respectively, from Rabaptin-5 polypeptide chain. We also detected Rabaptin-5delta and Rabaptin-5gamma transcripts in human. The results of Southern blot analysis and human genome sequence analysis strongly suggest that these transcripts along with Rabaptin-5 and Rabaptin-4 are encoded by a single gene, RAB5EP, and differ due to alternative pre-mRNA splicing. Although Rabaptin-5delta and Rabaptin-5gamma transcripts are low-abundant compared to Rabaptin-5 mRNA, their ubiquitous expression patterns might point on significant roles played by encoded by them proteins.
Assuntos
Proteínas de Transporte/genética , Proteínas de Membrana/genética , RNA Mensageiro/genética , Proteínas de Transporte Vesicular , Processamento Alternativo , Animais , Sequência de Bases , Éxons , Expressão Gênica , Genes/genética , Humanos , Íntrons , Camundongos , Dados de Sequência Molecular , Isoformas de Proteínas/genética , RNA Mensageiro/metabolismo , Transcrição GênicaRESUMO
MAK-V/Hunk is a scantily characterized AMPK-like protein kinase. Recent findings identified MAK-V as a pro-survival and anti-apoptotic protein and revealed its role in embryonic development as well as in tumorigenesis and metastasis. However molecular mechanisms of MAK-V action and regulation of its activity remain largely unknown. We identified Nedd4 as an interaction partner for MAK-V protein kinase. However, this HECT-type E3 ubiquitin ligase is not involved in the control of MAK-V degradation by the ubiquitin-proteasome system that regulates MAK-V abundance in cells. However, Nedd4 in an ubiquitin ligase-independent manner rescued developmental defects in Xenopus embryos induced by MAK-V overexpression, suggesting physiological relevance of interaction between MAK-V and Nedd4. This identifies Nedd4 as the first known regulator of MAK-V function.
Assuntos
Complexos Endossomais de Distribuição Requeridos para Transporte/metabolismo , Proteínas Quinases/metabolismo , Ubiquitina-Proteína Ligases/metabolismo , Animais , Western Blotting , Cicloeximida/farmacologia , Eletroforese em Gel de Poliacrilamida , Complexos Endossomais de Distribuição Requeridos para Transporte/genética , Humanos , Camundongos , Ubiquitina-Proteína Ligases Nedd4 , Células PC12 , Ligação Proteica , Proteínas Quinases/genética , Ratos , Ubiquitina-Proteína Ligases/genética , Ubiquitinação/efeitos dos fármacos , Proteínas de XenopusRESUMO
Intracellular membrane transport from the plasma membrane is one of the processes affected in apoptotic cells. Apoptotic inhibition of endosomal transport occurs due to cleavage of Rabaptin-5, an effector of small GTPase Rab5, which results in inhibition of early endosome fusion. Recently several novel Rabaptin-5-like proteins were identified. We investigated whether Rabaptin-5-like proteins, Rabaptin-5gamma and Rabaptin-5delta, are also cleaved in apoptosis and found that both proteins are cleaved in apoptotic cell extracts by caspase-3-related proteases. This suggests that functional inactivation of these proteins is necessary for apoptotic cell death. We also mapped a novel, N-terminal, putative Rab5 binding site in Rabaptin-5-like proteins, which becomes physically separated from the previously known C-terminal Rab5 binding site after apoptotic cleavage of these proteins. Presence of the second Rab5 binding site provides a new insight into Rabaptin-5 function in early endosome fusion and a mechanistic model for functional inactivation of Rabaptin-5 in apoptosis.
Assuntos
Apoptose , Proteínas de Transporte Vesicular/genética , Animais , Células COS , Caspase 3 , Caspases/metabolismo , Chlorocebus aethiops , Endossomos/fisiologia , Etoposídeo/farmacologia , Proteínas de Fluorescência Verde/genética , Células HL-60/efeitos dos fármacos , Humanos , Fusão de Membrana , Mutação , Isoformas de Proteínas/genética , Proteínas Recombinantes de Fusão/metabolismo , Transfecção , Técnicas do Sistema de Duplo-Híbrido , Proteínas rab5 de Ligação ao GTP/genética , Proteínas rab5 de Ligação ao GTP/metabolismoRESUMO
MAK-V/Hunk is a MARK/Par-1-related protein kinase, whose function is unknown. We studied the subcellular localization of MAK-V/Hunk in COS-1 cells by immunofluorescence. It has a nucleocytoplasmic distribution and is localized to the centrosome, as indicated by co-localization with gamma-tubulin. A putative kinase-deficient mutant, with a mutation in the invariant lysine residue in the catalytic domain, was not targeted to the nucleus or centrosome. These results suggest that the nuclear and centrosomal targeting of MAK-V/Hunk is specific, and is likely to be coupled to its catalytic activity.
Assuntos
Proteínas Quinases/análise , Transporte Ativo do Núcleo Celular , Substituição de Aminoácidos , Animais , Anticorpos Monoclonais , Células COS , Domínio Catalítico , Linhagem Celular , Centrossomo/química , Centrossomo/enzimologia , Chlorocebus aethiops , Imunofluorescência , Expressão Gênica , Camundongos , Plasmídeos , Proteínas Quinases/genética , Proteínas Quinases/metabolismo , Proteínas Serina-Treonina QuinasesRESUMO
BACKGROUND: Recent studies indicate that the innate component of immune defense plays an important role in the establishment of antigen-specific immune response. We have previously isolated a novel mouse gene tag7/PGRP that was shown to be involved in the innate component of the immune system, and its insect homologue is an upstream mediator of Toll signaling in Drosophila. METHODS: Transiently or stably genetically modified mouse tumor cell lines expressing Tag7 were used. Tumor growth rate and animal survival were analyzed. Possible effector cells involved in tumor suppression were detected immunohistochemically. RESULTS: Transfection of mammary gland adenocarcinoma cells with the tag7 cDNA did not alter their growth rate in vitro but diminished their tumorogenicity in vivo in syngeneic and immunodeficient animals. Increased incidence of apoptosis was registered in the modified tumors. Transient expression of Tag7 by mouse melanoma M3 cells elicited protective immunity against parental tumor cells. Immunohistochemical analysis revealed that tumors after immunization with the genetically modified cells were infiltrated with Mac1(+) cells, B220(+) cells, and NK cells. Using nude mice we observed rejection of modified cells, but did not detect memory formation. CONCLUSIONS: We can conclude that secretion of the Tag7 protein by genetically modified cells can induce mobilization of antigen-presenting cells and innate effectors. Memory mechanisms are mediated by T cell response. For the first time our results demonstrate that local secretion of Tag7-the molecule involved in innate immunity-may play an important role in the induction of effective antitumor response in mice.
Assuntos
Citocinas/metabolismo , Imunoterapia , Animais , Apoptose , Linhagem Celular Tumoral , Citocinas/genética , Citocinas/imunologia , Imunidade Inata , Imuno-Histoquímica , Camundongos , Especificidade da Espécie , Linfócitos T/imunologiaRESUMO
The peptidoglycan recognition protein Tag7 is shown to form a stable 1:1 complex with the major stress protein Hsp70. Neither protein is cytotoxic by itself, but their complex induces apoptotic death in several tumor-derived cell lines even at subnanomolar concentrations. The minimal part of Hsp70 needed to evoke cytotoxicity is residues 450-463 of its peptide-binding domain, but full cytotoxicity requires its ATPase activity; remarkably, Tag7 liberated from the complex at high ATP is not cytotoxic. The Tag7-Hsp70 complex is produced by tag7-transfected cells and by lymphokine-activated killers, being assembled within the cell and released into the medium through the Golgi apparatus by a mechanism different from the commonly known granule exocytosis. Thus, we demonstrate how a heat shock protein may perform functions clearly distinct from chaperoning or cell rescue and how peptidoglycan recognition proteins may be involved in innate immunity and anti-cancer defense.